Cosciens Biopharma Inc
(CSCIF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1999 | 12-1998 | |
| Sales | 4,150 | 4,450 |
| Cost of Goods | 680 | 0 |
| Gross Profit | 3,460 | 4,450 |
| Operating Expenses | 10,950 | 8,170 |
| Operating Income | -6,800 | -3,720 |
| Other Income | 4,150 | 1,070 |
| Pre-tax Income | -2,650 | -2,650 |
| Net Income Continuous | -2,650 | -2,650 |
| Net Income | $-2,650 | $-2,650 |
| EBITDA(a) | $-6,110 | $-3,390 |